1 December 2021
Office of Drug Control suspends cultivation and manufacture licences of Queensland Medicinal Cannabis Licence Holder
7 July 2021
The Amendment Act provides for amendments to the Narcotic Drugs Act 1967 to support an innovative Australian medicinal cannabis industry for the benefit of Australian patients.
4 February 2021
Introduction of the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021
10 December 2020
On 2 December 2020, Australia voted at the Commission on Narcotic Drugs on six recommendations concerning the scheduling of cannabis and cannabis related substances
13 November 2020
The ODC is seeking comments on a review of the structure, design and administrative processes relating to medicinal cannabis related permits
2 November 2020
Cost recovery arrangements for cannabis-related manufacture licences and permits commenced on 1 November 2020.
6 October 2020
From 1 November 2020, subject to formal approval from the Federal Executive Council, cost recovery arrangements will be extended to cannabis-related manufacture licences and permits under the Medicinal Cannabis Scheme.
27 July 2020
Changes to fees and charges related to the Medicinal Cannabis Scheme under the Narcotic Drugs Act 1967 commenced on 15 July 2020
29 June 2020

From 1 January 2021, proposed regulations would prohibit the importation of e-cigarettes containing vaporiser nicotine.